# TMRW Life Sciences, Inc. — Form D

TMRW Life Sciences, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-24. The offering totals $38.4M, of which $38.4M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2026-04-24
- Form: D
- Accession: 0001759388-26-000003
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $38.4M
- Amount sold: $38.4M
- Investors: 59
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-581848

## Issuer

- Name: TMRW Life Sciences, Inc.
- CIK: 0001759388
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 250 HUDSON STREET SUITE 102, NEW YORK, NY, 10013
- Phone: 917-525-3453

## Officers, directors & promoters (24)

| Name | Role | Location |
| --- | --- | --- |
| Emily Drabant Conley | Related Person | New York, NY |
| Greg Eisner | Related Person | New York, NY |
| Jeffrey Port | Related Person | New York, NY |
| William Schoolcraft | Related Person | New York, NY |
| Andrew Schwab | Related Person | BOSTON, MA |
| Vinay Shah | Related Person | New York, NY |
| Louis Villalba | Related Person | New York, NY |
| Andrew Schwab | Director | BOSTON, MA |
| Alan Murray | Director | Irving, TX |
| Emily Conley | Director | Berkeley, CA |
| Vinay Shah | Director | New York, NY |
| Joshua Abram | Director | New York, NY |
| Andrew Drabant Schwab | Director | New York, NY |
| Vinay Drabant Shah | Director | New York, NY |
| Roberta Drabant Myers | Director | New York, NY |
| Alan Drabant Murray | Director | New York, NY |
| Emily Drabant Conley | Director | New York, NY |
| Louis Drabant Villaba | Director | New York, NY |
| Jeffrey Drabant Port | Director | New York, NY |
| Jeffrey Port | Director | New York, NY |
| MELANIE GOLDEY | Executive Officer | NEW YORK, NY |
| Tara Comonte | Director | New York, NY |
| Tara Comonte | Executive Officer | New York, NY |
| Roberta Myers | Director | New York, NY |

## Other filings by this issuer (6)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-07-12](https://search.stillhousedata.com/formd/0001759388-24-000001) | D | $30.0M | $28.2M |
| [2022-05-13](https://search.stillhousedata.com/formd/0001013594-22-000436) | D/A | $102.2M | $100.2M |
| [2021-07-15](https://search.stillhousedata.com/formd/0001013594-21-000599) | D | $80.2M | $80.2M |
| [2021-02-12](https://search.stillhousedata.com/formd/0001013594-21-000122) | D | $20.0M | $20.0M |
| [2020-05-19](https://search.stillhousedata.com/formd/0001013594-20-000508) | D/A | $36.5M | $36.5M |
| [2019-12-23](https://search.stillhousedata.com/formd/0001013594-19-000770) | D | $29.0M | $29.0M |

## More

- [CIK 1759388 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1759388&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001759388-26-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.